Papers

1

Total Citations

2

H-Index

1

About

Dr. Rhonda Benton is a health outcomes researcher whose work centers on the comparative effectiveness and cost-efficiency of advanced radiation oncology techniques. Her primary research areas include health economics, decision modeling, and the evaluation of emerging cancer therapies. Her most notable contribution is a seminal 2011 study employing a Markov model decision analysis to compare the cost effectiveness of stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) for low- and intermediate-risk prostate cancer. This work provided critical, evidence-based insights for clinicians and policymakers navigating the trade-offs between treatment efficacy, patient convenience, and healthcare expenditure. While her highly focused, specialized paper has garnered 2 citations, its impact lies in establishing a rigorous methodological framework for evaluating emerging radiation technologies. Dr. Benton’s research exemplifies the growing importance of health economics in oncology, helping to ensure that innovative treatments are both clinically effective and economically sustainable.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Cost Effectiveness Analysis of Stereotactic Body Radiation Therapy (SBRT) versus Intensity Modulated Radiation Therapy (IMRT) for Low or Intermediate Risk Prostate Cancer: A Markov Model Decision Analysis
2 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: The University of Texas Southwestern Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago